سرمایه گذاران سازنده Ozempic Novo Nordisk با نگرانی به آینده نگاه می کنند

Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future

Novo Nordisk’s chief executive, Mike Doustdar, is a year into a corporate turnaround. He says investors are still underestimating the promise of the company’s drugs.